학술논문
545P Completion of pembrolizumab in advanced non-small cell lung cancer: Real-world outcomes after two years of therapy (COPILOT).
Document Type
Article
Author
Source
Subject
*NON-small-cell lung carcinoma
*CANCER prognosis
*PEMBROLIZUMAB
*
*
Language
ISSN
0923-7534